<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Myriad Genetics 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=22349></link><description><![CDATA[Myriad Genetics 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 19:34:48 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><language>ko-KR</language><item><title><![CDATA[Crescendo Bioscience&#039;s Vectra(R) DA Predicts Radiographic Progression in Patients With Early Rheumatoid Arthritis]]></title><link>https://www.newswire.co.kr/newsRead.php?no=750022</link><description><![CDATA[SALT LAKE CITY--(Korea Newswire)--Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (Nasdaq:MYGN), today announced the online publication of a new study in the journal Annals of the Rheumatic Diseases for Crescendo's Vectra DA blood test. The study is a retrospective analysis of data from the Swedish Farmacotherapy (SWEFOT) clinical trial and shows that Ve...]]></description><pubDate>Wed, 14 May 2014 20:05:00 +0900</pubDate></item></channel></rss>